|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2008.19.0819 on October 14 2008 © 2008 American Society of Clinical Oncology.
Skin-Sparing Intensity-Modulated Radiotherapy of the Breast
Department of Radiation Oncology, University Hospital Düsseldorf, Düsseldorf, Germany
Department of Dermatology, University Hospital Düsseldorf, Düsseldorf, Germany
Department of General, Visceral and Pediatric Surgery, University Hospital Düsseldorf, Düsseldorf, Germany To the Editor: We read with great interest the recent article by Jean-Philippe Pignol et al1 and the comment by Vordermark2 regarding a multicenter, double-blind, randomized clinical trial testing whether breast intensity-modulated radiation therapy (BIMRT) reduces the rate of acute skin reaction (notably moist desquamation), decreases pain, and finally improves the quality of life as compared with standard radiotherapy using wedges. We would like to note that with regard to recent studies from other institutes, observations of grade 3 and 4 skin toxicity rates of 36.7% (standard radiotherapy) and 27.1% (BIMRT) are a poor result. Notably, Osako et al3 showed that in 377 patients treated with conventional radiotherapy, only 77 (20%) and six (2%) had grade 2 or grade 3 radiation dermatitis, respectively. Even better results were achieved with hypofractionated radiotherapy. This is in accordance with observations in our institution. Furthermore, in our opinion, a long-term follow-up of 10 years would be necessary to support a general recommendation of BIMRT for breast cancer. Only with long-term follow-up can local control, overall survival, and cosmetic results be reliably evaluated. Taken together, at this stage we do not recommend the use of BIMRT as a standard procedure for breast cancer therapy. AUTHORS DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The author(s) indicated no potential conflicts of interest. NOTES published online ahead of print atwww.jco.org on October 13, 2008 REFERENCES
1. Pignol JP, Olivotto I, Rakovitch E, et al: A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26:2085-2092, 2008 2. Vordermark D: Skin-sparing intensity-modulated radiotherapy of the breast. J Clin Oncol 26:3292, 2008 3. Osako T, Oguschi M, Kumada M, et al: Acute radiation dermatitis and pneumonitis in Japanese cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy. Jpn Clin Oncol 38:334-338, 2008[CrossRef]
Related Reply
Related Articles
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|